Henrietta Nittby Redebrandt Selected Research

vacquinol-1

2/2018

Evaluating vacquinol-1 in rats carrying glioblastoma models RG2 and NS1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Henrietta Nittby Redebrandt Research Topics

Disease

8	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 02/2018
8	Neoplasms (Cancer) 01/2023 - 11/2016
2	Glioma (Gliomas) 12/2021 - 11/2016
1	Myocardial Infarction 02/2023
1	Cerebral Hemorrhage 02/2023
1	Hematoma 02/2023
1	Adenocarcinoma 10/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2019
1	Brain Neoplasms (Brain Tumor) 02/2018

Drug/Important Bio-Agent (IBA)

2	AntibodiesIBA 01/2021 - 12/2018
2	Complement System Proteins (Complement)IBA 10/2019 - 12/2018
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	C-Reactive ProteinIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 10/2019
1	Messenger RNA (mRNA)IBA 10/2019
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2018
1	vacquinol-1IBA 02/2018
1	inositol trispyrophosphateIBA 11/2016

Therapy/Procedure

4	Radiotherapy 01/2023 - 01/2020
3	Therapeutics 01/2023 - 02/2018
1	Artificial Respiration (Mechanical Ventilation) 02/2023
1	Craniotomy 02/2023
1	Immunotherapy 01/2023
1	Euthanasia (Mercy Killing) 01/2023
1	Chemoradiotherapy 12/2021